Navigation Links
CardioDynamics Reports Second Fiscal Quarter 2009 Results
Date:7/9/2009

% lower BioZ sales, partially offset by 8% growth in recurring sensor revenue. Sensor revenue grew 11% sequentially from first quarter 2009 to $1.9 million, recording the third consecutive quarter of sensor growth, averaging 10% growth over the three quarters. Gross margin as a percentage of sales decreased from 71% to 67% in the second quarter of 2009, largely due to a $3,000, or 10% decline in the average BioZ unit sales price in the direct domestic market resulting from a discount sales promotion offered during the second quarter. Operating expenses were essentially unchanged at $4.9 million compared with second quarter 2008. The second quarter of 2009 included approximately $250,000 of merger transaction-related expenses. Operating cash use was $340,000, an improvement of 31%, or $150,000, from $490,000 in the same quarter of 2008.

CEO Comments and Outlook

Michael K. Perry, Chief Executive Officer of CardioDynamics, stated, "We navigated through a tough quarter relatively well and were pleased with the third consecutive quarter of sensor revenue growth and 11% sequential revenue growth for the business. Economic conditions continue to put pressure on capital equipment spending in healthcare and this has affected demand for our BioZ systems. We are excited to join SonoSite, an industry leader in point of care medicine who shares our vision of creating non-invasive technologies that improve outcomes and reduce the cost of patient care. Being part of a larger company platform will provide additional resources that should enable accelerated growth for ICG technology in the years ahead."

Conference Call Information

Due to the merger with SonoSite which was announced on June 9, 2009, there will not be a quarterly financial conference call. The transaction is subject to shareholder approval and customary closing conditions and is anticipated to close during the third quarter of calendar 2009.<
'/>"/>

SOURCE CardioDynamics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CardioDynamics Announces Third Quarter 2007 Conference Call and Webcast
2. CardioDynamics Announces Strategic Alliance With Leading Medical Equipment Manufacturer in India
3. CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007
4. CardioDynamics Board of Directors Proposes Reverse Split 1:7 of Companys Shares
5. CardioDynamics Reports 22% Revenue Growth in First Quarter 2008
6. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
7. CardioDynamics Announces Second Quarter 2008 Conference Call and Webcast
8. CardioDynamics Reports Second Fiscal Quarter 2008 Results, 18% Revenue Increase for First Half 2008
9. CardioDynamics Announces Investors Retain $5.25 Million 8% Convertible Debt Securities
10. CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008
11. CardioDynamics Reports First Quarter 2009 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... were treated with cisplatin-based chemotherapy ha... side effects and Raynaud-like phenomena, than men... to a new study published online November 25 in th...Marianne Brydy, M.D., of the Department of Oncolog...y, and colleagues conducted a cross-sectional stud...
(Date:11/25/2009)...thritis, could help newly diagnosed diabetics, stu...ay News) -- A drug commonly used to treat non-Hodg...hows some promise in helping patients newly diagno... (Rituxan), helped patients keep producing some of...stroyed some of their pancreatic beta cells, which...
(Date:11/25/2009)...incare ®isproudtosupportGNC,seffortstoraisemo...de ThanksandGiving campaign,$1fromthepurchaseprice... willbedonatedtoSt.Jude.Additionally,GNCcustomersh...utatoneoftheir5,000+retaillocationsoratGNC.com.GNC...2009 ThanksandGiving campaign. ,, "Wearedelight...
(Date:11/25/2009)... in children with autism and related conditions ca...edication combined with a structured training prog...archers and their colleagues. , Published in th...can Academy of Child and Adolescent Psychiatry , t...f Mental Health (NIMH) Research Units on Pediatric...
(Date:11/25/2009)...emier resource for life science careers and inform...™ Hotbed Campaign this morning. , ...2009 -- BioSpace.com, the premier resource for lif...ird edition of the BioForest™ Hotbed Campaig... a promotional effort highlighting biotechnology, ...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...ew, expanded broad-spectrum IV antibiotic that can...ctions including those caused by antibiotic// resi...ylococcus aureus (MRSA). It will be available in t...re running out of options. "Difficult to tre...
...due to anthrax being confirmed from Koothattukulam...taken preventive measures to contain the spread of...es collected from of the carcasses of one the cows...re conducted at the Avian Diseases Diagnostic Regi...
...al cord injury who experience recurring problems ...ssive therapy to avoid further cardiovascular// pr... Medical College of Georgia. A study subset ...ient, says Dr. Andres F. Ruiz-Arango, cardiology f...
...lantic University, the Center for Breast Care at t..., and MeVis, The Center for Diagnostic// Systems a...any have developed new techniques to aid clinician...imaging techniques for the analysis and display of...
...s, the labs of Yale Goldman, MD, PhD, Director of ...y of Pennsylvania School of Medicine,// and Erika ...shed a group of papers that, taken together, show ...ead to better ways to treat motor neuron diseases....
... in Australia to help men manage with breast cance...so that men who are diagnosed// every year have th...er Center (NBCC) maintains the website. It w...d that the new website will provide specific infor...
Other Medicine News:Health News:Broad Spectrum Antibiotic Available for Antibiotic Resistant Bacteria 2Health News:Aggresive Therapy Needed for Cervical Spinal Cord Injuries 2Health News:Aggresive Therapy Needed for Cervical Spinal Cord Injuries 3Health News:New Tool to Diagnose and Treat Breast Cancer 2Health News:New Tool to Diagnose and Treat Breast Cancer 3Health News:Discovery of Agile Molecular Motors Could Aid in Treating Motor Neuron Diseases 2
(Date:11/25/2009)...NCETON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmass...lcompanycommittedtodiscovering,developingandcommer...financialresultsforthefiscalyearendedSeptember30,2...cash,cashequivalentsandshortterminvestments. ,,...,, Phase2bTrial ,, InlateNovember2009,an...
(Date:11/25/2009)...ON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGroup,...ra report,thefirstinamulti-phasesyndicatedmarketr...tech,sStelara,fromproductlaunchthroughthefirstsixm...ntitativeinformationfrom75uniqueDermatologistsandq...esstrialanduseofStelara,obstaclestouse,typicalpati...
(Date:11/25/2009)...LEGEPARK,Md.,Nov.25/PRNewswire-USNewswire/--Remedi...-likefoamthatstopsseverebleeding,wonfirstprizeand$...lobalSecurityChallenge2009,companyofficialsannounc...oundtheworld,Remedium,steampitchedtheirinventionat...lofBusiness. ,, Remedium( www.remediumtechnolog...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Sexist jokes favor the mental mechanisms that justify violence against women 50661 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 2UT multimedia program increases middle school interest in science 9105 1UT multimedia program increases middle school interest in science 9105 2SETO Holdings Inc Announces Opening of its Richmond Virginia Location 50658 1
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: